FDA now issues export certificates and documents electronically for medical device manufacturers and other stakeholders
Updates to the regulation include alignment with administrative provisions from the RDC 751/2022 on medical devices and some hints on what to expect next.
We take a look back at some of the most significant medical device and IVD regulatory and compliance developments of 2023.
In this on-demand webinar, our Emergo by UL subject matter expert outlines the latest insights about integrated risk management.
Learn best practices for integrating UI design validation into HF validation tests to support a smooth and productive endeavor.
Threshold Analysis and FDA Expectations | Emergo by UL
On November 30, 2023, the FDA announced in the Federal Register its intention to classify certain types of wound dressings that had remained unclassified as pre-amendment devices; i.e., devices that were in commercial distribution before enactment of the Medical Device Amendments of May 28, 1976.
EU medical device makers and clinical investigation sponsors should review updated FAQs from MDCG regarding significant changes to the clinical investigations section of MDR 2017/745.
In this on-demand webinar, our Emergo by UL subject matter expert outlines the latest insights about EU MDR PMS, including PMCF and vigilance.
Emergo by UL professionals gave an update on EU Medical Devices Regulation (MDR, 2017/745) and In Vitro Diagnostic Devices Regulation (IVDR, 2017/746) compliance.